Researchers with the FDA’s Office of Prescription Drug Promotion (OPDP) plan to investigate the influence of targeted mechanism of action (targeted MoA) claims, graphics and disclosures that provide context about a drug’s targeted MoA. In 2014, OPDP conducted focus groups designed to provide insights on how consumers and health care providers (HCP), including physicians, nurs... Read More